Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Primary Myelofibrosis × venetoclax × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 3 Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Primary Myelofibrosis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Amyloidosis 1

Interventions

venetoclax 1 selinexor 1 ruxolitinib 1 navitoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03592576 2024-05-06

Expanded Access to Navitoclax

AbbVie

No longer available

LymphoidMyeloidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡